| NDC Code | 0409-7295-17 |
|---|
| Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-7295-17) > 15 mL in 1 VIAL, SINGLE-DOSE (0409-7295-27) |
|---|
| Product NDC | 0409-7295 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Potassium Phosphates |
|---|
| Non-Proprietary Name | Potassium Phosphate, Monobasic And Potassium Phosphate, Dibasic |
|---|
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20140701 |
|---|
| Marketing Category Name | UNAPPROVED DRUG OTHER |
|---|
| Manufacturer | Hospira, Inc. |
|---|
| Substance Name | POTASSIUM PHOSPHATE, MONOBASIC; POTASSIUM PHOSPHATE, DIBASIC |
|---|
| Strength | 224; 236 |
|---|
| Strength Unit | mg/mL; mg/mL |
|---|
| Pharmacy Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
|---|